Literature DB >> 5126939

Baker's yeast cytosine deaminase. Some enzymic properties and allosteric inhibition by nucleosides and nucleotides.

P L Ipata, F Marmocchi, G Magni, R Felicioli, G Polidoro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5126939     DOI： 10.1021/bi00799a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  8 in total

1.  Presence of a specific uridine 5'-monophosphate pyrophosphorylase in baker's yeast.

Authors:  P Natalini; E Fioretti; S Ruggieri; A Vita; G Magni
Journal:  Experientia       Date:  1975-09-15

2.  Effect of pyrophosphate and orotidine monophosphate on cytosine deaminase regulatory properties.

Authors:  T P West
Journal:  Experientia       Date:  1985-12-15

3.  Utilization of exogenous pyrimidines as a source of nitrogen by cells of the yeast Rhodotorula glutinis.

Authors:  O A Milstein; M L Bekker
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

4.  Baker's yeast cytidine deaminase: substrate and inhibitor specificity, and a hypothesis on metabolic and regulatory significance.

Authors:  G Magni; P Ipata; P Natalini; R A Felicioli; G Cercignani
Journal:  Experientia       Date:  1974-08-15

5.  Cytosine deaminase: structural modifications studies.

Authors:  S Yergatian; J B Lee; M J Geisow; J C Ireson
Journal:  Experientia       Date:  1977-12-15

6.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy.

Authors:  L D Stegman; A Rehemtulla; B Beattie; E Kievit; T S Lawrence; R G Blasberg; J G Tjuvajev; B D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

7.  Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer.

Authors:  Stacy E Martin; Tanushree Ganguly; Gerhard R Munske; Melody D Fulton; Mark R Hopkins; Clifford E Berkman; Margaret E Black
Journal:  Bioconjug Chem       Date:  2014-09-15       Impact factor: 4.774

Review 8.  Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy.

Authors:  Ashraf S A El-Sayed; Nabil Z Mohamed; Marwa A Yassin; Mahmoud M Amer; Reyad El-Sharkawy; Nesma El-Sayed; Mostafa G Ali
Journal:  Heliyon       Date:  2022-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.